| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.26 | 0.4 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.06 | 0.4 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.4 |